Practice
Featured experience
Cerebras Systems $6.4 billion IPO
We advised the underwriters on the IPO
Alphabet $20 billion notes offering
We advised the global coordinators and book-running managers on the offering
Arxis $1.3 billion IPO
We advised Arxis on its IPO
Novartis $11 billion notes offering
We advised Novartis on the investment-grade debt offering
Ormat Technologies $1 billion convertible senior notes offering
We advised the representatives of the several initial purchasers on the offering
Nestlé Capital $2 billion notes offering and concurrent tender offers
We advised the book-running managers on the offering and the dealer managers on the tender offer
Albemarle cash tender offers
We advised the dealer manager on the tender offers
Novartis $11 billion notes offering
We advised Novartis on the investment-grade debt offering
Versigent $1.6 billion senior notes offering
We advised Versigent on the offering, which is being made in conjunction with Aptiv’s planned spinoff of Versigent
PAR Technology $265 million convertible senior notes offering
We advised the representative of the initial purchasers on the offering
Amazon.com €14.5 billion notes offering
We advised the underwriters on the offering
Morgan Stanley $6 billion senior notes offering
We advised Morgan Stanley on its SEC-registered global offering
UBS $3.05 billion senior notes offering
We advised the representative of the agents on the offering
CRISPR Therapeutics $600 million convertible notes offering
We advised the initial purchasers on the offering